China Health Group Inc Sustainability Reports
The company provides contract research organization (CRO) services, clinical research, post-market drug development, and scientific commercialization solutions. It also engages in the research, development, and technological transfer of bio-pharmaceuticals, medical products, and synthetic drugs.
Sector: Professional & technical services
Country: China
Exchange: Hong Kong Stock Exchange
LEI: 254900PWX6498SJFLW25
FIGI: BBG001SDCQ25
1 reports from 2019 to 2019
